These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598 [Abstract] [Full Text] [Related]
3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use. Petitti DB, Porterfield D. Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340 [Abstract] [Full Text] [Related]
4. Oral contraceptives and gynecologic cancer: an update for the 1990s. Kaunitz AM. Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442 [Abstract] [Full Text] [Related]
5. Noncontraceptive health benefits of oral steroidal contraceptives. Mishell DR. Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):809-16. PubMed ID: 7065059 [Abstract] [Full Text] [Related]
6. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM, Coeytaux RR, Urrutia RP, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER. Obstet Gynecol; 2013 Jul 15; 122(1):139-147. PubMed ID: 23743450 [Abstract] [Full Text] [Related]
7. On the epidemiology of oral contraceptives and disease. Prentice RL, Thomas DB. Adv Cancer Res; 1987 Jul 15; 49():285-401. PubMed ID: 3314396 [Abstract] [Full Text] [Related]
9. Whitlock EP, Williams SB, Burda BU, Feightner A, Beil T. ; 2015 09 15. PubMed ID: 26491756 [Abstract] [Full Text] [Related]
10. The pill and cancer: a review of the literature. A case of swings and roundabouts? Knowlden HA. J Adv Nurs; 1990 Sep 15; 15(9):1016-20. PubMed ID: 2229699 [Abstract] [Full Text] [Related]
11. Neoplastic effects of oral contraceptives. Grimes DA. Int J Fertil; 1991 Sep 15; 36 Suppl 1():19-24. PubMed ID: 1678377 [Abstract] [Full Text] [Related]
12. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers. Michels KA, Pfeiffer RM, Brinton LA, Trabert B. JAMA Oncol; 2018 Apr 01; 4(4):516-521. PubMed ID: 29346467 [Abstract] [Full Text] [Related]
13. The safety of oral contraceptives: epidemiologic insights from the first 30 years. Grimes DA. Am J Obstet Gynecol; 1992 Jun 01; 166(6 Pt 2):1950-4. PubMed ID: 1605284 [Abstract] [Full Text] [Related]
14. [Oral contraceptives and endometrial and ovarian carcinomas]. Medl M. Gynakol Geburtshilfliche Rundsch; 1998 Jun 01; 38(2):105-8. PubMed ID: 9815528 [Abstract] [Full Text] [Related]
15. Oral contraceptives and cancer. Edgren RA. Int J Fertil; 1991 Jun 01; 36 Suppl 3():37-50. PubMed ID: 1687403 [Abstract] [Full Text] [Related]
16. Oral contraceptive health benefits: perception versus reality. Kaunitz AM. Contraception; 1999 Jan 01; 59(1 Suppl):29S-33S. PubMed ID: 10342094 [Abstract] [Full Text] [Related]
17. Researchers can now investigate long-term effects of OCs on cancer. Rubin GL, Peterson HB. Contracept Technol Update; 1985 Jan 01; 6(1):7-12. PubMed ID: 12279918 [Abstract] [Full Text] [Related]
18. Long-term health risks and benefits of oral contraceptive use. Peterson HB, Lee NC. Obstet Gynecol Clin North Am; 1990 Dec 01; 17(4):775-88. PubMed ID: 2092241 [Abstract] [Full Text] [Related]
19. [Oral contraception and its beneficial gynecological effects]. Belaisch J, Hommais-loufrani B. Fertil Contracept Sex; 1988 Mar 01; 16(3 Suppl):3-7. PubMed ID: 12282188 [Abstract] [Full Text] [Related]
20. Cancer of the breast and reproductive tract in relation to use of oral contraceptives. Schlesselman JJ. Contraception; 1989 Jul 01; 40(1):1-38. PubMed ID: 2673658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]